Corcept Therapeutics CORT
NASDAQ CORT
$111.62 -1.18 (-1.05%)
As of: Sep 4, 2026 · 3:59 PM EDT

Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2026)

Corcept Therapeutics (CORT) posted Exchange Rate Effect of $37000.0 for Q2 2026, up 112.89% sequentially from -$287000.0 in Q1 2026, and down 97.42% YoY from $1.4 million in Q2 2025.

Analysis

Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2026) Analysis & Trends

Corcept Therapeutics has reported Exchange Rate Effect for 3 years, with the latest figure at $37000.0 in Q2 2026.

  • Quarterly Exchange Rate Effect fell 97.42% year-over-year to $37000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$602000.0 (down 138.3% YoY) and the FY2025 annual result came in at $1.4 million, up 732.46% from the prior year.
  • Exchange Rate Effect improved to $37000.0 in Q2 2026 per CORT's latest filing, from -$287000.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $1.4 million in Q2 2025 and troughed at -$758000.0 in Q4 2024.
  • A 3-year average of $121250.0 and a median of $2500.0 in 2025 frame the typical range for Exchange Rate Effect.
  • The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect soared 95.78% in 2025, then plunged 180.17% in 2026.
  • Over 3 years, Exchange Rate Effect stood at -$758000.0 in 2024, then jumped by 95.78% to -$32000.0 in 2025, then jumped by 215.62% to $37000.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered $37000.0, -$287000.0, and -$32000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -3.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -300,000.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -2.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 19.84 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.45 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -287,000.00
10 Corcept Therapeutics 11.76 Bn 11.46 Bn 252.09 Mn 37,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37,000.00
Mar 31, 2026 -287,000.00
Dec 31, 2025 -32,000.00
Sep 30, 2025 -320,000.00
Jun 30, 2025 1.44 Mn
Mar 31, 2025 358,000.00
Dec 31, 2024 -758,000.00
Sep 30, 2024 536,000.00